Skip to content
Home/Companies/Biotech/Libragen

Libragen

Biotech·France·Exited 2011·Held 7yr
Entry
2004
Hold
7yr
Exit
2011

Who owns Libragen?

Libragen is a French Biotech company, now owned by Induchem, which acquired it in 2011 from Galia Gestion.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Galia Gestion
Investor
Galia Gestion
Galia Investissements I · 2002

Key facts

HQFrance
SectorBiotech
Exit Type
Trade Sale
Buyer
Induchem
Exit Year
2011

More from Galia Investissements I

Other portfolio companies in the same fund.

H&A Location
H&A Location
Active
IndustrialsFrance
ChannelFret International
Active
IndustrialsFrance· 2025
LOCACONCEPT
Locaconcept
Exited 2021
ConsumerFrance· 2016
to BNP Paribas Développement
OCTIME
Octime
Exited 2012
HR TechFrance· 2008
to MYEFFICO
BREF
Exited 2015
IndustrialsFrance· 2007
Ceit Entreprises
Exited 2013
IndustrialsFrance· 2007

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Libragen?

Libragen is now owned by Induchem, which acquired it in 2011 from Galia Gestion.

When did Induchem acquire Libragen?

Induchem acquired Libragen in 2011, buying from Galia Gestion.

Who did Libragen sell to?

Galia Gestion sold Libragen to Induchem in 2011 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue